Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T16:08:38.546Z.
Consensus retrieved: 2026-10-06T13:56:54.998Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T16:08:38.546Z.
Quote observation: 2026-10-06T16:03:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d441fe8f086afba93fb8397567d44bfe794a39cd606e17fb54204e4f45075d8b
Forward PE Ratio (N/A) = Dated Quote Price ($0.74) / Consensus Forward EPS ($-0.12)
FORWARD PE RATIO
N/A
MIRA Pharmaceuticals, Inc.
Market Cap
$31.20M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| MIRA Pharmaceuticals, Inc. (MIRA) | $31.20M | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $30.90M | N/A |
| MDxHealth S.A. (MDXH)vs › | $30.82M | N/A |
| Nortech Systems Incorporated (NSYS)vs › | $31.77M | N/A |
| BeyondSpring Inc. (BYSI)vs › | $30.58M | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $32.14M | 9.52 |
| HeartBeam, Inc. (BEAT)vs › | $32.32M | N/A |
| Rockwell Medical, Inc. (RMTI)vs › | $32.50M | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.88M | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.82M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $0.74, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-0.12 | $-0.12 – $-0.12 | 1 | n/m |
| 2027-12-31 | $-0.16 | $-0.16 – $-0.16 | 1 | n/m |
| 2028-12-31 | $-0.18 | $-0.18 – $-0.18 | 1 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
